P Franchimont
- Molecular Biology
- Reproductive Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Social Psychology top 10%
- Public Health, Environmental and Occupational Health
- Co-authors
- Dominique CroixReginster JyJ.J. LegrosS. ChariA. ReuterJean‐Yves ReginsterA DemoulinJ.C. Hendrick
- Topics
- Bone health and osteoporosis research (9 papers)Growth Hormone and Insulin-like Growth Factors (8 papers)Bone health and treatments (7 papers)
- Journals
- Annals of the New York Academy of SciencesBritish Journal of CancerCellular and Molecular Life Sciences
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
P Franchimont
79 papers receiving 835 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 202
- Reproductive Medicine 185
- Endocrinology, Diabetes and Metabolism 173
- Social Psychology 147
- Public Health, Environmental and Occupational Health 116
Countries citing papers authored by P Franchimont
This map shows the geographic impact of P Franchimont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Franchimont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Franchimont more than expected).
Fields of papers citing papers by P Franchimont
This network shows the impact of papers produced by P Franchimont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Franchimont. The network helps show where P Franchimont may publish in the future.
Co-authorship network of co-authors of P Franchimont
This figure shows the co-authorship network connecting the top 25 collaborators of P Franchimont. A scholar is included among the top collaborators of P Franchimont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Franchimont. P Franchimont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Acute biochemical variations induced by four different calcium salts in healthy male volunteers | 2 |
| 2 | Traitement de l'ostéoporose: données actuelles et perspectives | 1 |
| 3 | Efficacy and tolerance of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone | 2 |
| 4 | Long term (3 years) prevention of trabecular postmenopausal bone loss with low dose intermittent nasal salmon calcitonin | 0 |
| 5 | Bone mineral content of lumbar spine and hip in a normal european female population: comparison of dual photon absorptiometry and quantitative digital radiology | 1 |
| 6 | Relation between calcium intake during different periods of life and bone mineral content at the menopause | 1 |
| 7 | Normal values for lumbar and femoral bone mineral density in Western European postmenopausal females, comparison of dual photon absorptiometry and quantitative digital radiography | 0 |
| 8 | Effects of different calcium formulations on calcium absorption in healthy volunteers | 0 |
| 9 | Treatment of Paget's disease of bone with high doses of oral tiludronate given during a five-day course therapy | 1 |
| 10 | The effect of salmon calcitonin on blood-ionized calcium in the presence of anti-salmon calcitonin antibodies (from pagetic patients) in young rabbits | 7 |
| 11 | Normal values for lumbar and femoral bone mineral density in western european postmenopausal females, comparison of dual photon absorptiometry and quantitative digital radiology | 0 |
| 12 | Short-term therapy of Paget's disease of bone by increasing doses of a new bisphosphonate: chloro-4-thiomethylene bisphosphonate | 1 |
| 13 | (Chloro-4 phenyl) thiomethylene bisphosphonate in Paget’s bone disease | 1 |
| 14 | Hypocalcémie induite chez le sujet pagétique par la calcitonine salmine nasale. Effets des anticorps anti-calcitonine salmine | 1 |
| 15 | Nasal calcitonin in prevention of early postmenopausal bone loss. A 18-month study | 1 |
| 16 | Prevention of early postmenopausal bone loss by intranasal calcitonin - a controlled, randomised study lasting one year in normal women | 9 |
| 17 | La calcitonine 25 ans après | 2 |
| 18 | Side effect of SSCT given by intranasal spray compared with intra-muscular injection. | 2 |
| 19 | Serum and erythrocyte magnesium in osteoporotic and osteoarthritic postmenopausal women | 4 |
| 20 | [Radioimmunologic assay of alpha-fetoprotein in various normal and pathological conditions]. | 1 |
About P Franchimont
P Franchimont is a scholar working on Reproductive Medicine, Orthopedics and Sports Medicine and Endocrinology, Diabetes and Metabolism, having authored 96 papers that have together received 924 indexed citations. Recurring topics across this work include Bone health and osteoporosis research (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Bone health and treatments (7 papers). The work is most often cited by research in Reproductive Medicine (185 citations), Behavioral Neuroscience (54 citations) and Endocrine and Autonomic Systems (101 citations). P Franchimont has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Dominique Croix, Reginster Jy, J.J. Legros, S. Chari, A. Reuter, Jean‐Yves Reginster, A Demoulin, J.C. Hendrick, Rita Deroisy and R.D. Bulbrook. Their work appears in journals such as Annals of the New York Academy of Sciences, British Journal of Cancer and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.